Oppenheimer Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
16,195
+2,202
| +16% | +$277K | 0.02% | 547 |
|
|
2025
Q1 | $1.55M | Buy |
13,993
+49
| +0.4% | +$5.42K | 0.02% | 599 |
|
|
2024
Q4 | $1.9M | Buy |
13,944
+186
| +1% | +$25.4K | 0.02% | 549 |
|
|
2024
Q3 | $1.59M | Sell |
13,758
-1,388
| -9% | -$160K | 0.02% | 614 |
|
|
2024
Q2 | $2.09M | Buy |
15,146
+1,725
| +13% | +$237K | 0.03% | 511 |
|
|
2024
Q1 | $1.85M | Sell |
13,421
-2,056
| -13% | -$284K | 0.03% | 512 |
|
|
2023
Q4 | $2.04M | Sell |
15,477
-452
| -3% | -$59.6K | 0.03% | 510 |
|
|
2023
Q3 | $1.79M | Buy |
15,929
+1,736
| +12% | +$195K | 0.03% | 527 |
|
|
2023
Q2 | $1.34M | Sell |
14,193
-12,027
| -46% | -$1.13M | 0.02% | 612 |
|
|
2023
Q1 | $2.65M | Sell |
26,220
-196
| -0.7% | -$19.8K | 0.04% | 418 |
|
|
2022
Q4 | $3.16M | Sell |
26,416
-3,833
| -13% | -$458K | 0.05% | 365 |
|
|
2022
Q3 | $3.21M | Sell |
30,249
-3,444
| -10% | -$366K | 0.06% | 338 |
|
|
2022
Q2 | $3.29M | Sell |
33,693
-920
| -3% | -$89.7K | 0.06% | 347 |
|
|
2022
Q1 | $3.25M | Buy |
34,613
+8,179
| +31% | +$767K | 0.05% | 399 |
|
|
2021
Q4 | $2.25M | Sell |
26,434
-2,362
| -8% | -$201K | 0.03% | 520 |
|
|
2021
Q3 | $2.76M | Buy |
28,796
+354
| +1% | +$34K | 0.04% | 428 |
|
|
2021
Q2 | $2.77M | Buy |
28,442
+674
| +2% | +$65.6K | 0.04% | 442 |
|
|
2021
Q1 | $2.7M | Buy |
27,768
+2,532
| +10% | +$246K | 0.04% | 427 |
|
|
2020
Q4 | $2.42M | Sell |
25,236
-639
| -2% | -$61.3K | 0.04% | 423 |
|
|
2020
Q3 | $2.49M | Buy |
25,875
+16,149
| +166% | +$1.55M | 0.05% | 381 |
|
|
2020
Q2 | $1.19M | Buy |
9,726
+785
| +9% | +$95.8K | 0.02% | 547 |
|
|
2020
Q1 | $774K | Buy |
8,941
+1,383
| +18% | +$120K | 0.02% | 621 |
|
|
2019
Q4 | $812K | Buy |
7,558
+82
| +1% | +$8.81K | 0.02% | 683 |
|
|
2019
Q3 | $674K | Buy |
7,476
+204
| +3% | +$18.4K | 0.02% | 729 |
|
|
2019
Q2 | $614K | Sell |
7,272
-203
| -3% | -$17.1K | 0.01% | 763 |
|
|
2019
Q1 | $659K | Buy |
7,475
+700
| +10% | +$61.7K | 0.01% | 719 |
|
|
2018
Q4 | $484K | Buy |
+6,775
| New | +$484K | 0.01% | 777 |
|